ArticleInfection and drug resistance2025
Impact of Patient-Centered Care on Treatment Outcomes of Multidrug-Resistant/Rifampicin-Resistant Tuberculosis in Xi'an.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Economic burden of MDR/RR-TB and implementation of a treatment subsidy policy in Lishui City, China: a retrospective study following strobe guidelines.BMC health services research · 2026Article
- Nano-Infrared Detection and Identification of Bacteria at the Single-Cell Level.Analytical chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: A hospital in Xi'an, Shaanxi Province, China, implemented patient-centered care services to improve the treatment outcomes of patients with multidrug-resistant/rifampicin-resistant tuberculosis. Given the high recurrence rate and treatment challenges of this disease, this study aimed to evaluate the effects of patient-centered care services compared to standard care in improving patient treatment adherence and reducing loss to follow-up. Methods: This single-center retrospective cohort study included multidrug-resistant/rifampicin-resistant tuberculosis patients diagnosed and treated at the Xi'an Tuberculosis Prevention and Treatment Hospital from January 2018 to December 2019. Descriptive statistics, survival analysis, and multivariate Cox regression analysis were used to analyze the impact of patient-centered care services on treatment adherence. Data collection included patients' demographic characteristics, clinical data, treatment outcomes, and reasons for loss to follow-up. Results: A total of 429 patients were included in the final analysis, with 166 in the standard-of-care group and 263 in the patient-centered care services group. The treatment success rate in the patient-centered care services group (86.3%) was significantly higher than the standard of care group (59.0%), and the loss to follow-up rate was significantly lower (6.8% vs 30.1%). Multivariate analysis showed that patient-centered care services significantly reduced the risk of loss to follow-up (adjusted odds ratio of 0.14). The main reasons for the loss of follow-up included economic difficulties, lack of knowledge, and inadequate social support. Conclusion: The patient-centered care services model significantly improved the treatment success rate and reduced the loss to follow-up rate for multidrug-resistant/rifampicin-resistant tuberculosis patients, demonstrating potential benefits in managing drug-resistant tuberculosis. Based on these findings, exploring and optimizing the patient-centered care services model in other high-burden areas is recommended to enhance overall treatment outcomes and quality of life for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.